3 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks) and about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks) lost 20% of body weight, alongside diet and exercise
Allergen immunotherapy (desensitisation), where indicated and available in line with BSACI guidance and NICE CKS criteria can provide long-term symptom relief without the need for ongoing pharmacological management
Here's everything you need to know about Wegovy prices with and without insurance, and how to save on your medication
As the obesity epidemic continues to strain healthcare systems globally, the demand for effective pharmacological interventions is only expected to grow
The ideal clinical candidate is an adult experiencing symptoms of hormonal decline, such as fatigue, loss of muscle mass, and persistent abdominal fat, who is seeking deeper metabolic optimization through high-purity compounding pharmacy protocols rather than relying on the ineffective quick fixes commonly marketed online